This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Katholieke Universiteit Leuven, Prometheus Biosciences, Inc.. Active years: 2020.
Company Filing History:
1 out of 630 
1 out of 15 
Years Active: 2020
Title: The Innovative Contributions of Marc Ferrante
Introduction
Marc Ferrante is a notable inventor based in Leuven, Belgium. He has made significant contributions to the field of medical technology, particularly in the area of predicting post-operative outcomes for patients with Crohn's disease. His work has the potential to improve patient care and surgical outcomes.
Latest Patents
Marc Ferrante holds a patent titled "Methods for predicting post-operative recurrence of Crohn's disease." This invention provides methods for predicting whether a patient undergoing surgical treatment for Crohn's disease is at risk of developing histological, radiographic, endoscopic, and/or clinical recurrence of the disease. This patent is a testament to his innovative approach to addressing complex medical challenges. He has 1 patent to his name.
Career Highlights
Throughout his career, Marc has worked with prominent organizations, including Prometheus Biosciences, Inc. and Katholieke Universiteit Leuven. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Steven Lockton and Severine Vermiere. Their collaborative efforts have further advanced the research and development of innovative solutions in the medical field.
Conclusion
Marc Ferrante's contributions to the field of medical technology, particularly in predicting post-operative outcomes for Crohn's disease, highlight his innovative spirit and dedication to improving patient care. His work continues to inspire advancements in medical research and technology.